Log in  First Connection?

Parkinson's Disease: Archives News of the month

Early phase Amyloid‐PET reproduces metabolic signatures of cognitive decline in Parkinson's disease

 Published on 02/04/2025 |  Original article (Abstract)  | Campbell Le Heron et al. | Alzheimer's & dementia : the journal of the Alzheimer's Association 2024; 20(S2): 091211

Cognition‐related Network Organization in Parkinson's Disease with Mild Cognitive Impairment and Dementia

 Published on 26/03/2025 |  Original article (Abstract)  | Yoshikazu Nakano et al. | Alzheimer's & dementia : the journal of the Alzheimer's Association 2024; 20(S2): 084270

Periodic and Aperiodic Components of Subthalamic Nucleus Activity Reflect Different Aspects of Motor Impairment in Parkinson's Disease

 Published on 19/03/2025 |  Original article (Abstract)  | Ksenia Sayfulina et al. | European Journal of Neuroscience 2025; 61(1): 16648

Neurophysiology of Parkinson's disease, one of the most common neurodegenerative disorders, has been extensively studied, yet many questions remain unanswered. A critical area of investigation involves identifying specific electrophysiological biomarkers associated with the motor symptoms of Parkinson's...

Still Functional but Limited Postural Adaptation for Individuals With Parkinson's Disease in Goal‐Directed Visual Tasks

 Published on 12/03/2025 |  Original article (Abstract)  | Cédrick T et al. | European Journal of Neuroscience 2025; 61(1): 16646

Parkinson's disease (PD) is a neurodegenerative disease resulting in motor and cognitive impairments (Allen, Schwarzel, and Canning 2013; Papagno and Trojano 2018; Rowe et al. 2002). These impairments worsen the person's quality of life and interfere with postural stability during suprapostural...

New Multiomic Studies Shed Light on Cellular Diversity and Neuronal Susceptibility in Parkinson's Disease

 Published on 05/03/2025 |  Original article (Abstract)  | Marianna Liang BS et al. | Movement Disorders 2025; AOP: 10.1002/mds.30097

By the time Parkinson's disease (PD) is clinically diagnosed, it is estimated that 60% to 80% of dopaminergic neurons (DANs) have already degenerated, suggesting that the neurodegenerative process begins years before the onset of motor symptoms. Previous studies have identified a spatial vulnerability...